X
ORKA

Xponance’s Oruka Therapeutics ORKA Stock Holding History

Xponance’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$469K Buy
+4,927
New +$328K ﹤0.01% 1133

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Xponance's ORKA Position: Q2 2026 in Review

Xponance opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 4,927 shares worth $469K. The stake represents ﹤0.01% of the portfolio and ranks #1133 among its holdings.

255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Xponance held 4,927 shares of Oruka Therapeutics worth $469K as of Q2 2026.
  • Oruka Therapeutics was a new Xponance position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1133 holding.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.